ClosedFind a Tender · tender Update
NP39726 Generic and Biosimilar Cancer Medicines
BuyerThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
StatusClosed
Deadline26 Aug 2026
Value£197,026,942
Published30 Jul 2026
What is being bought
Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.
Categories
Pharmaceutical products 33600000
Comparable-procurement analytics
Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Pharmaceutical products (33600000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.
| Comparison set | Procedures | Reported bids per procedure | Named award suppliers | Price evidence |
|---|---|---|---|---|
| Market: CPV division 33 | 1,792 | 2 median · 104.8 average (601 of 1,792 with a bid count) | 6.3 average (698 of 1,792 with named award suppliers) | Not published |
| Same buyer | 13 | 13 median · 13 average (2 of 13 with a bid count) | 9.8 average (4 of 13 with named award suppliers) | Not published |
| Similar published value (0.5×–2×) | 58 | Not published | Not published | Not published |
“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.
Price-outcome signal
Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.
Procurement strategy & market signals
Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published
Planning & early market engagement
BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0
No planning milestones published.
Related procurements
No linked framework, prior procurement or reprocurement published.
Documents & submission route
No documents are published in the current source record.
Source data inventory
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-06d3b5 |
|---|---|
| Latest release ID | 072326-2026 |
| Latest release timestamp | Thu Jul 30 2026 14:49:26 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | Not published |
| Tender status | Not published |
| Procurement method | Not published |
| Procurement method details | Not published |
| Main procurement category | goods |
| Above threshold | Not published |
| Legal basis | 32014L0024 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 0 |
| Tender items in source | 0 |
| Tender documents in source | 0 |
| Awards in latest release | 0 |
| Contracts in latest release | 0 |
| Parties in latest release | 1 |
Notice history
| Date | Event | Reference |
|---|---|---|
| 30 Jul 2026 | tenderUpdate | 072326-2026 |
| 24 Jul 2026 | tender | 070486-2026 |
All source data
Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "072326-2026",
"tag": [
"tenderUpdate"
],
"date": "2026-07-30T15:49:26+01:00",
"ocid": "ocds-h6vhtk-06d3b5",
"buyer": {
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000838357"
}
],
"tender": {
"id": "ocds-h6vhtk-06d3b5",
"title": "NP39726 Generic and Biosimilar Cancer Medicines",
"amendments": [
{
"id": "1",
"description": "Delay to publishing ITT requiring extension to the ITT deadline to compensate.",
"unstructuredChanges": [
{
"where": {
"label": "Time limit",
"section": "IV.2.2"
},
"newValue": {
"date": "2026-09-01T12:00:00+01:00"
},
"oldValue": {
"date": "2026-08-26T12:00:00+01:00"
}
},
{
"where": {
"label": "Conditions for opening of tenders",
"section": "IV.2.7"
},
"newValue": {
"date": "2026-09-01T12:00:00+01:00"
},
"oldValue": {
"date": "2026-08-26T12:00:00+01:00"
}
}
]
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)",
"roles": [
"buyer"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "1 South Gyle Crescent."
},
"details": {
"url": "http://publicservicesdelivery.scot/about/procurement/",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883"
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"contactPoint": {
"email": "Cameron.Wright@nhs.scot",
"telephone": "+44 1312756000"
}
}
],
"language": "en",
"initiationType": "tender"
}Complete JSON history (2 releases)
30 Jul 2026 · 072326-2026 · tenderUpdate
{
"id": "072326-2026",
"tag": [
"tenderUpdate"
],
"date": "2026-07-30T15:49:26+01:00",
"ocid": "ocds-h6vhtk-06d3b5",
"buyer": {
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000838357"
}
],
"tender": {
"id": "ocds-h6vhtk-06d3b5",
"title": "NP39726 Generic and Biosimilar Cancer Medicines",
"amendments": [
{
"id": "1",
"description": "Delay to publishing ITT requiring extension to the ITT deadline to compensate.",
"unstructuredChanges": [
{
"where": {
"label": "Time limit",
"section": "IV.2.2"
},
"newValue": {
"date": "2026-09-01T12:00:00+01:00"
},
"oldValue": {
"date": "2026-08-26T12:00:00+01:00"
}
},
{
"where": {
"label": "Conditions for opening of tenders",
"section": "IV.2.7"
},
"newValue": {
"date": "2026-09-01T12:00:00+01:00"
},
"oldValue": {
"date": "2026-08-26T12:00:00+01:00"
}
}
]
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)",
"roles": [
"buyer"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "1 South Gyle Crescent."
},
"details": {
"url": "http://publicservicesdelivery.scot/about/procurement/",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883"
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"contactPoint": {
"email": "Cameron.Wright@nhs.scot",
"telephone": "+44 1312756000"
}
}
],
"language": "en",
"initiationType": "tender"
}24 Jul 2026 · 070486-2026 · tender
{
"id": "070486-2026",
"tag": [
"tender"
],
"date": "2026-07-24T16:59:46+01:00",
"ocid": "ocds-h6vhtk-06d3b5",
"buyer": {
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000838357"
}
],
"tender": {
"id": "ocds-h6vhtk-06d3b5",
"lots": [
{
"id": "1",
"title": "Bendamustine powder for solution for infusion vials",
"value": {
"amount": 169388,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Lot 1 Bendamustine powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "2",
"title": "Capecitabine tablets",
"value": {
"amount": 590765,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Capecitabine tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "4",
"title": "Cisplatin solution for infusion vials",
"value": {
"amount": 1008289,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Cisplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "5",
"title": "Cyclophosphamide powder for solution for injection vials",
"value": {
"amount": 338258,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Cyclophosphamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "6",
"title": "Cytarabine solution for injection vials",
"value": {
"amount": 122307,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Cytarabine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "7",
"title": "Dacarbazine powder for solution for injection/infusion vials",
"value": {
"amount": 250217,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Dacarbazine powder for solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "8",
"title": "Disodium folinate solution for injection vials",
"value": {
"amount": 283496,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Disodium folinate solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "9",
"title": "Docetaxel solution for infusion vials",
"value": {
"amount": 808420,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Docetaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "11",
"title": "Fluorouracil 25mg/ml solution for injection/infusion vials",
"value": {
"amount": 231402,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Fluorouracil 25mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "12",
"title": "Fluorouracil 50mg/ml solution for injection/infusion vials",
"value": {
"amount": 1432949,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Fluorouracil 50mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "13",
"title": "Gemcitabine 38mg/ml solution for infusion vials",
"value": {
"amount": 310860,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Gemcitabine 38mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "14",
"title": "Gemcitabine 100mg/ml solution for infusion vials",
"value": {
"amount": 313655,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Gemcitabine 100mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "15",
"title": "Ifosfamide powder for solution for injection vials",
"value": {
"amount": 1759061,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Ifosfamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "17",
"title": "Methotrexate solution for injection/infusion vials",
"value": {
"amount": 490564,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Methotrexate solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "18",
"title": "Oxaliplatin solution for infusion vials",
"value": {
"amount": 349538,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Oxaliplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "19",
"title": "Paclitaxel solution for infusion vials",
"value": {
"amount": 2541766,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Paclitaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "20",
"title": "Temozolomide capsules",
"value": {
"amount": 257799,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Temozolomide capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "21",
"title": "Vincristine solution for injection vials",
"value": {
"amount": 91122,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Vincristine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "22",
"title": "Vinorelbine solution for infusion vials",
"value": {
"amount": 24630,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Vinorelbine solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "23",
"title": "Aprepitant capsules",
"value": {
"amount": 873964,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Aprepitant capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "24",
"title": "Octreotide solution for injection ampoules",
"value": {
"amount": 897199,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Octreotide solution for injection ampoules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "25",
"title": "Filgrastim solution for injection pre-filled syringes",
"value": {
"amount": 4796431,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Filgrastim solution for injection pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "26",
"title": "Pemetrexed powder for solution for infusion vials",
"value": {
"amount": 14436,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Pemetrexed powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "27",
"title": "Pemetrexed solution for infusion vials",
"value": {
"amount": 1347937,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Pemetrexed solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "29",
"title": "Dasatinib tablets",
"value": {
"amount": 1038368,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Dasatinib tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "30",
"title": "Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines",
"value": {
"amount": 30972852,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework agreement to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "31",
"title": "Lenalidomide capsules",
"value": {
"amount": 912775,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Lenalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"name": "Pregnancy Prevention Programme (PPP)",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "90"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "32",
"title": "Pomalidomide capsules",
"value": {
"amount": 4619961,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire"
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Pomalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"name": "Pregnancy Prevention Programme (PPP)",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "90"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "33",
"title": "Thalidomide capsules",
"value": {
"amount": 428163,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Thalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"name": "Pregnancy Prevention Programme (PPP)",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "90"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "16",
"title": "Irinotecan solution for infusion vials",
"value": {
"amount": 751953,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Irinotecan solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "28",
"title": "Etoposide solution for infusion vials",
"value": {
"amount": 984935,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Etoposide solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "10",
"title": "Doxorubicin solution for injection vials",
"value": {
"amount": 277294,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Doxorubicin solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "3",
"title": "Carboplatin solution for infusion vials",
"value": {
"amount": 3480542,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Carboplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "34",
"title": "Lenvatinib capsules",
"value": {
"amount": 11600324,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of Lenvatinib capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-05-01T00:00:00+01:00"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "35",
"title": "Range of ranked cancer medicine lines",
"value": {
"amount": 45208332,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of a range of ranked cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
},
{
"id": "36",
"title": "Range of single-supplier cancer medicine lines",
"value": {
"amount": 32684852,
"currency": "GBP"
},
"status": "active",
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"hasOptions": false,
"hasRenewal": true,
"description": "Supply of a range of single-supplier cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per product line. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"contractPeriod": {
"endDate": "2029-01-31T23:59:59Z",
"startDate": "2027-02-01T00:00:00Z"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "5",
"relatedLot": "5",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "6",
"relatedLot": "6",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "7",
"relatedLot": "7",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "8",
"relatedLot": "8",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "9",
"relatedLot": "9",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "11",
"relatedLot": "11",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "12",
"relatedLot": "12",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "13",
"relatedLot": "13",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "14",
"relatedLot": "14",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "15",
"relatedLot": "15",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "17",
"relatedLot": "17",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "18",
"relatedLot": "18",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "19",
"relatedLot": "19",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "20",
"relatedLot": "20",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "21",
"relatedLot": "21",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "22",
"relatedLot": "22",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "23",
"relatedLot": "23",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "24",
"relatedLot": "24",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "25",
"relatedLot": "25",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "26",
"relatedLot": "26",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "27",
"relatedLot": "27",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "29",
"relatedLot": "29",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "30",
"relatedLot": "30",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "31",
"relatedLot": "31",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "32",
"relatedLot": "32",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "33",
"relatedLot": "33",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "16",
"relatedLot": "16",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "28",
"relatedLot": "28",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "10",
"relatedLot": "10",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "34",
"relatedLot": "34",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "35",
"relatedLot": "35",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "36",
"relatedLot": "36",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP39726 Generic and Biosimilar Cancer Medicines",
"value": {
"amount": 197026942,
"currency": "GBP"
},
"status": "active",
"coveredBy": [
"GPA"
],
"bidOpening": {
"date": "2026-08-26T12:00:00+01:00"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lotDetails": {
"maximumLotsBidPerSupplier": null
},
"techniques": {
"frameworkAgreement": {
"maximumParticipants": null
},
"hasFrameworkAgreement": true
},
"awardPeriod": {
"startDate": "2026-08-26T12:00:00+01:00"
},
"description": "Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.",
"tenderPeriod": {
"endDate": "2026-08-26T12:00:00+01:00"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"hasRecurrence": false,
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"submissionMethod": [
"electronicSubmission"
],
"procurementMethod": "open",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"appliesTo": [
"supplier"
],
"description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"minimum": "(a)\tConfirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines by the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(b)\tConfirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.\n(c)\tConfirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.\n(d)\tA completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.",
"appliesTo": [
"supplier"
],
"description": "(a)\tPotential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines by the start date of the Framework Agreement.\n(b)\tPotential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.\n(c)\tAll tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.\n(d)\tPotential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond."
}
]
},
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)",
"roles": [
"buyer",
"centralPurchasingBody"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "1 South Gyle Crescent."
},
"details": {
"url": "http://publicservicesdelivery.scot/about/procurement/",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"contactPoint": {
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"email": "Cameron.Wright@nhs.scot",
"telephone": "+44 1312756000"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"details": {
"url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk"
}
}
],
"language": "en",
"description": "The estimated values referred to in Section II.1.5 and within all Lots covers the twenty four(24) month contract duration and the twenty (24) month extension period of the framework agreement.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 32105. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nIt is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework.\nPotential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved.\nPotential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.\nFor further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/).\n(SC Ref:838357)",
"initiationType": "tender"
}